The AHA today submitted comments on the Centers for Medicare & Medicaid Services’ outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2021. The association continues its “steadfast opposition” to any payment cuts made to 340B hospitals, arguing that the Department of Health and Human Services “does not have the legal authority to punitively target 340B hospitals.”

Citing patient safety risks, AHA also strongly opposed the rule’s proposals to eliminate the inpatient-only list, remove certain restrictions on the expansion of physician-owned hospitals that qualify as high-Medicaid facilities, and change the ASC covered procedures list. The association applauded CMS’ proposed changes to the hospital overall star ratings. Read the full letter for AHA’s detailed comments on the rule.

Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The AHA will host a webinar May 21 at 1 p.m. ET on key proposed changes to the fiscal year 2027 inpatient prospective payment system from the Centers for…
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B…